Stonegate Healthcare Partners Announces Black Friday Biotech Special Report For an "XBI-MAS"

Dallas, Texas--(Newsfile Corp. - November 24, 2023) - Stonegate Healthcare Partners highlights a unique opportunity in its report, "Black Friday Biotech Sale: 12 Stocks for XBI-MAS." Despite overall market health, biotech stocks have significantly declined, with the XBI biotech index 56% lower than its 5-year high, and 30% of NASDAQ-listed biotech companies trading at negative enterprise value.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

• The Black Friday Winter 2023 shopping list - carefully curated from the top 1% of publicly traded biotech companies.
• Our focus is on companies with institutional support, robust pipelines, upcoming milestones, and strong management teams.
• The top three companies the shopping list are aTyr Pharma, Rezolute (NASDAQ: RZLT), and Vincerx Pharma.

Click image above to view full announcement.

About Stonegate Healthcare Partners

At Stonegate Healthcare Partners our mission is to accelerate meaningful innovations in healthcare through Strategy, Market Intelligence, Business Development and Investor Outreach. The firm's research approach is centered on comprehensive and comparative analyses in specific healthcare fields. We aim to identify programs with high synergy to our strategic understanding of the space and technologies with the highest disruptive potential. Stonegate Healthcare builds on its foundational thematic research by continuously gathering market intelligence, enabling a current understanding of unmet need and emerging disruptive technologies. 

Contacts:

Stonegate Healthcare Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate Healthcare

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/188620